By the bioMérieux Connection Editors The University of Antwerp has announced the creation of an Innovative Medicines Initiative (IMI) called VALUE-Dx, in partnership with bioMérieux and Wellcome Trust. According to the University of Antwerp, “The purpose of VALUE-Dx is to transform medical practice to achieve more personalized, evidence-based antibiotic prescription and use in community care …
bioMérieux Partners in Ambitious Initiative to Promote the Value of Innovative Diagnostic Tests in Battling Antibiotic Resistance
